Pfizer Inc. Files 8-K on Shareholder Votes
Ticker: PFE · Form: 8-K · Filed: Apr 28, 2025 · CIK: 78003
| Field | Detail |
|---|---|
| Company | Pfizer Inc (PFE) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing-update
Related Tickers: PFE
TL;DR
Pfizer filed an 8-K on shareholder votes, standard corporate update.
AI Summary
Pfizer Inc. filed an 8-K on April 28, 2025, reporting on matters submitted to a vote of security holders as of April 24, 2025. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31). It also lists the company's principal executive offices located at 66 Hudson Boulevard East, New York, NY.
Why It Matters
This filing provides transparency regarding corporate governance and shareholder decisions at Pfizer Inc., which can influence investor confidence and company strategy.
Risk Assessment
Risk Level: low — This is a routine corporate filing detailing a vote of security holders and does not indicate any unusual financial or operational risks.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of Pfizer's annual financial reporting period.)
- 20250424 — Date of Earliest Event Reported (The date on which the reported event (submission to vote) occurred.)
Key Players & Entities
- Pfizer Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- New York (location) — Principal executive offices city
- 66 Hudson Boulevard East (address) — Principal executive offices street
FAQ
What specific matters were submitted to a vote of Pfizer's security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on April 24, 2025.
What is Pfizer Inc.'s state of incorporation?
Pfizer Inc. is incorporated in Delaware.
Where are Pfizer Inc.'s principal executive offices located?
Pfizer Inc.'s principal executive offices are located at 66 Hudson Boulevard East, New York, New York.
What is Pfizer Inc.'s fiscal year end?
Pfizer Inc.'s fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding PFIZER INC (PFE).